Inventor · disambiguated record
Jing Zhou
Also filed as: ZHOU JING · ZHOU JING S · ZHOU JING SHI
13 granted patents·20 pending applications·28 citations·filing 2003–2024
88Inventor score
Files withINCYTE CORP7CELL SIGNALING TECHNOLOGY INC6LEE STEVE S4NOVARTIS AG3SICHUAN KELUN PHARM RES INST CO LTD2
Top patents by PatentIndex Score
33 records- 0186US9862764B2Compositions and methods for antibodies targeting BMP6CONG FENG·Filed 2015·Granted Jan 9, 2018·8 cites·54 claims
- 0284US11377486B2Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residueCELL SIGNALING TECHNOLOGY INC·Filed 2019·Granted Jul 5, 2022·2 cites·6 claims
- 0382US10683346B2Compositions and methods for antibodies targeting BMP6NOVARTIS AG·Filed 2017·Granted Jun 16, 2020·2 cites·20 claims
- 0481US7645466B2Methods for deriving, isolating, and/or extracting amino acid compositions from Fenugreek seedTSI GROUP LTD·Filed 2005·Granted Jan 12, 2010·4 cites·16 claims
- 0575US2025059293A1Cd73 inhibitor and a2a/a2b adenosine receptor inhibitor combination therapyINCYTE CORP·Filed 2024·Application pending·0 cites
- 0673US10493054B2Docetaxel albumin nanoparticle pharmaceutical composition, preparation method therefor and use thereofSICHUAN KELUN PHARM RES INST CO LTD·Filed 2016·Granted Dec 3, 2019·2 cites·22 claims
- 0773US2024352143A1Anti-cd73 antibodies and uses thereofINCYTE CORP·Filed 2024·Application pending·0 cites
- 0872US11434269B2Methods for treating disease using inhibitors of bone morphogenetic protein 6 (BMP6)NOVARTIS AG·Filed 2017·Granted Sep 6, 2022·1 cites·25 claims
- 0972US9249231B2Motif-specific and context-independent antibodies that specifically bind to a cleaved caspase motifCOMB MICHAEL·Filed 2011·Granted Feb 2, 2016·2 cites·16 claims
- 1072US7338675B2Fenugreek seed bio-active compositions and methods for extracting sameTSI HEALTH SCIENCES INC·Filed 2003·Granted Mar 4, 2008·7 cites·57 claims
- 1165US12018089B2Anti-CD73 antibodies and uses thereofINCYTE CORP·Filed 2020·Granted Jun 25, 2024·0 cites·27 claims
- 1265US11530261B2Compositions and methods for antibodies targeting BMP6NOVARTIS AG·Filed 2020·Granted Dec 20, 2022·0 cites·30 claims
- 1363US11395812B2Docetaxel albumin nanoparticle pharmaceutical composition, preparation method therefor and use thereofSICHUAN KELUN PHARM RES INST CO LTD·Filed 2019·Granted Jul 26, 2022·0 cites·14 claims
- 1462US12060433B2CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapyINCYTE CORP·Filed 2020·Granted Aug 13, 2024·0 cites·39 claims
- 1562US2023250190A1Binding domains against cancer-associated muc1MERUS NV·Filed 2022·Application pending·0 cites
- 1662US2025382250A1Stilbene derivative as ahr agonist and use thereofNANJING GRITPHARMACO LTD·Filed 2023·Application pending·0 cites
- 1761US2021205311A1Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 InhibitorsINCYTE CORP·Filed 2020·Application pending·0 cites
- 1858US2022233529A1Combination therapy comprising a2a/a2b inhibitors, pd-1/pd-l1 inhibitors, and anti-cd73 antibodiesINCYTE CORP·Filed 2021·Application pending·0 cites
- 1958US2023272055A1Anti-mutant calreticulin (calr) antibodies and uses thereofINCYTE CORP·Filed 2022·Application pending·0 cites
- 2056US2016319001A1Motif-Specific and Context-Independent Antibodies That Specifically Bind to a Cleaved Caspase MotifCELL SIGNALING TECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 2156US2025235543A1Modified proteins and protein degradersCULLGEN SHANGHAI INC·Filed 2022·Application pending·0 cites
- 2255US2009076111A1Methods for improving glycemic control in humansLEE STEVE S·Filed 2007·Application pending·0 cites
- 2355US2022062346A1USE OF miRNA IN PREPARATION OF A DRUG FOR PREVENTING AND TREATING OSTEOARTHRITIS, AN EXOSOME HIGHLY EXPRESSING miRNA AND USE THEREOFSUZHOU MUNICIPAL HOSPITAL NORTH DISTR·Filed 2021·Application pending·0 cites
- 2452US2005048147A1Compositions and methods for weight managementFiled 2004·Application pending·0 cites
- 2552US2005053679A1Methods for supporting metabolism and transportation of glucose and carbohydrates into muscleFiled 2004·Application pending·0 cites
- 2650US2010304406A1Protein Phosphorylation by Serine/Threonine Kinases in Insulin Signaling PathwaysCELL SIGNALING TECHNOLOGY INC·Filed 2009·Application pending·0 cites
- 2746US2005233013A1Methods for enhancing the transport of glucose for balancing blood sugar levelsLEE STEVE S·Filed 2005·Application pending·0 cites
- 2846US2005226948A1Methods for enhancing the transport of glucose into muscleLEE STEVE S·Filed 2005·Application pending·0 cites
- 2946US2005233014A1Methods for affecting homeostasis and metabolism in a mammalian bodyLEE STEVE S·Filed 2005·Application pending·0 cites
- 3038US2011059463A1Serine and Threonine Phosphorylation SitesCELL SIGNALING TECHNOLOGY INC·Filed 2010·Application pending·0 cites
- 3136US9856315B2Methylation and acetylation sitesCELL SIGNALING TECHNOLOGY INC·Filed 2015·Granted Jan 2, 2018·0 cites·10 claims
- 3236US2023263121A1Modulation of endogenous mogroside pathway genes in watermelon and other cucurbitsELO LIFE SYSTEMS·Filed 2021·Application pending·0 cites
- 3332US2011045603A1Serine, Threonine, and Tyrosine Phosphorylation SitesCELL SIGNALING TECHNOLOGY INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jing Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →